Bacillus clausii effects in children with allergic rhinitis.
Ciprandi
G
G
Allergologia-U.O. ORL, Padiglione Specialità (piano terzo), Ospedale San Martino, Largo R. Benzi 10, 16132 Genoa, Italy. gio.cip@libero.it
Vizzaccaro
A
A
Cirillo
I
I
Tosca
M A
MA
D000293:Adolescent; D001407:Bacillus; D017332:Cetirizine / Q000008:administration & dosage / Q000627:therapeutic use; D004311:Double-Blind Method; D004804:Eosinophils / Q000473:pathology; D005260:Female; D039563:Histamine H1 Antagonists, Non-Sedating / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009296:Nasal Cavity / Q000473:pathology / Q000503:physiopathology; D010865:Pilot Projects; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use; D019936:Probiotics / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome
D039563:Histamine H1 Antagonists, Non-Sedating; D010879:Piperazines; C472067:levocetirizine; D017332:Cetirizine